SpicyIP Tidbit: Now Pfizer Sues Ranbaxy


In SpicyIP’s 3 earlier posts, the on-going global struggle between Ranbaxy and Pfizer was reported. The latest news is that Pfizer has sued Ranbaxy alleging infringement of two of its Lipitor process patents. Here’s the complete article from MoneyControl: The world’s largest drug maker Pfizer has stepped up its offensive against Ranbaxy to block it from launching a generic version of its blockbuster heart drug Lipitor. Pfizer has sued Ranbaxy alleging that it has infringed two of Lipitor’s process patents…


Read More »

SpicyIP Tidbit: Govt. Disapproves Optical Policy Draft


In an earlier post by Sumathi, a reference was made to the optical disk legislation. Last November, it was reported that the Government was scrutinising the recommendations made with regard to the optical disk law to check piracy in the film industry. The draft law was prepared by members of the film industry along with FICCI at the initiative of the Government. According to the Business Line, a study titled “The Effects of Counterfeiting and Piracy on India’s Entertainment Industry”…


Read More »

SpicyIP Tidbit: Indian Pharma shows off its figure(s)


In continuation of an earlier piece blogged by Sumathi (with very comprehensive comments by sai which are a really interesting read) here is another post on Pharma MNC’s facing very stiff competition from their Indian counterparts. The Economic Times reports that Indian companies have trounced fears that global pharma MNC’s would dominate our domestic market in the product patent regime post 2005 as in the last year the market share of foreign companies has fallen from 24% to 22%. I…


Read More »
Trademark

SpicyIP Tidbit: Need for amending the Trademarks Act?


This article chronicles the remarks of senior officials citing the advantages of amending the Trademarks Act for accession to the Madrid Protocol. These changes are to be incorporated in the Trademark Amendment Bill currently with Parliament. The advantages of such amendments will be as follows: 1. Allowing Indian companies to apply for registration in multiple destinations from their local offices.2. An 18 month deadline will be applicable for Indian companies applying for trademarks.3. Global protection under the Madrid system can…


Read More »

Will the real NGO please stand up?


The Delhi High Court in its recent March 19thruling on the Roche-Cipla issue had lamented about the fact that it did not have access to any accurate information as to how many patients were affected by lung cancer and how many of them actually had access to Roche’s drug. A lack of quality empirical evidence has been a lamentable feature in all policy debates regarding patents in India. Three days after this judgment of the Delhi High Court a leading…


Read More »
Patent

Patents vs Patients: Cipla’s Victory and the Evolution of New “Compulsory Licensing” Norms


The verdict is finally out and we had blogged on the Roche vs CIPLA controversy here, here and here. More recently, Prashant did a short note on Justice Bhat’s judgment here. Extremely well researched judgment—I’m guessing that the judge was helped by a very bright law student (as law clerk). The influence of law clerks on the Indian judiciary is beginning to be felt and will make an excellent topic of research for those of you willing to investigate this…


Read More »

Big Pharma and neglected diseases


The BS and the Mint recently carried stories on Pfizer’s announcement that it will focus its R&D efforts on diseases affecting developing countries such as India. As of now Pfizer seeks to target diseases such as cancer, diabetes, neurological disorders and inflammation, with special emphasis on the regional characteristics of the ailments. Pfizer will also work on certain vaccines and other unmet medical needs. However it remains to be seen whether Pfizer actually translates its words into actions or whether…


Read More »

SpicyIP Tidbit: BBMP seeks to patent construction technology


The Hindu reports that the BBMP or the Bruhat Bangalore Mahanagar Palike is seeking to patent a novel technology which allows it to build an underpass for a fraction of its previous cost. While the usual cost of an underpass is usually Rs. 20 crores the novel technology would reduce costs to a mere Rs. 1 crore! The other huge advantage of these underpasses is that they take significantly lesser time to construct – a huge advantage in congested cities…


Read More »

SpicyIP Tidbit: Frontline’s interview with Dr. Baltimore


The Frontline one of India’s last few leftist news magazines’ (The cover story last month was a tribute to the ‘Living Legend‘- Castro, the week after that the cover story was an attack on the ‘Neo-liberal policies‘ of the UPA Govt.) carried a superbly detailed interview of Nobel Laureate David Baltimore. Dr. Baltimore shared the Nobel Prize for Physiology or Medicine with Howard Temin and Renato Dulbecco at the young age of 37. At the time, Baltimore’s greatest contribution to…


Read More »
Innovation

SpicyIp Tidbits:Google launches Open Social Foundation


The Open Social movement that was launched in November last year provides a common mechanism for developers to easily hook into many different social networks and extend their functionality. To further this initiative, Google has teamed up with Yahoo and My space to form the Open Social Foundation, a ‘non-profit, private foundation dedicated to the sustainable and open development of the Open Social initiative and related intellectual property.’ Open Social Foundation will be structured to include both corporate and individual…


Read More »